Company picked by Ottawa to produce made-in-Canada vaccines warns it may go out of business
Maryland-based Novavax told investors yesterday on a conference call that there is significant uncertainty surrounding the company's ability to continue funding operations. In February 2021, the federal government announced a deal with the company to begin producing its vaccine at a National Research Council facility in Montreal. Another company planning the commercial manufacture of COVID-19 vaccines in Canada, Quebec-based Medicago Inc., would be shut down.
Published 3 months ago · Ottawa, Canada
News Articles
More Filters
All
Left
Center
Right
Time & Location
Sources are mostly out of (0)
Bias Distribution
62% of the sources lean Left
+8
L 60%
C 25%
15%
See less detail
